Minimally Invasive Versus Conventional Aortic Valve Replacement: a Long Term Registry

NCT ID: NCT02278666

Last Updated: 2023-09-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-10-31

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the present study is to assess in a "real life" case list the outcome of three different surgical approaches for isolated aortic valve surgery in terms of surgery times, morbidity and mortality.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study will focus on data recorded and collected from daily clinical treatment of patients undergoing isolated aortic valve replacement due to symptomatic aortic stenosis who consented to the use of their personal data. After surgery patients will be followed up to a minimum of 12 months. In-hospital and follow-up outcomes of the different surgical approaches will be analysed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Aortic Valve Surgery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

upper mini-sternotomy

aortic valve replacement surgery via upper J or T sternotomy (ministernotomy)

aortic valve replacement

Intervention Type PROCEDURE

aortic valve replacement with either biological prosthetic valve or mechanical valve

biological prosthetic valve

Intervention Type DEVICE

aortic valve replacement with either biological prosthetic valve or mechanical valve

Mechanical valve

Intervention Type DEVICE

aortic valve replacement with either biological prosthetic valve or mechanical valve

right mini thoracotomy

aortic valve replacement/repair surgery via right mini thoracotomy

aortic valve replacement

Intervention Type PROCEDURE

aortic valve replacement with either biological prosthetic valve or mechanical valve

biological prosthetic valve

Intervention Type DEVICE

aortic valve replacement with either biological prosthetic valve or mechanical valve

Mechanical valve

Intervention Type DEVICE

aortic valve replacement with either biological prosthetic valve or mechanical valve

conventional sternotomy

aortic valve replacement surgery via conventional full sternotomy

aortic valve replacement

Intervention Type PROCEDURE

aortic valve replacement with either biological prosthetic valve or mechanical valve

biological prosthetic valve

Intervention Type DEVICE

aortic valve replacement with either biological prosthetic valve or mechanical valve

Mechanical valve

Intervention Type DEVICE

aortic valve replacement with either biological prosthetic valve or mechanical valve

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

aortic valve replacement

aortic valve replacement with either biological prosthetic valve or mechanical valve

Intervention Type PROCEDURE

biological prosthetic valve

aortic valve replacement with either biological prosthetic valve or mechanical valve

Intervention Type DEVICE

Mechanical valve

aortic valve replacement with either biological prosthetic valve or mechanical valve

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

AVR

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients undergoing isolated aortic valve surgery
* Written Informed consent to the use of personal data

Exclusion Criteria

* other associated cardiac surgery
* emergency surgery
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ettore Sansavini Health Science Foundation

OTHER

Sponsor Role collaborator

Maria Cecilia Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Elisa Mikus, MD

Role: PRINCIPAL_INVESTIGATOR

Maria Cecilia Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Maria Cecilia Hospital

Cotignola, Ravenna, Italy

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Italy

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ESREFO21

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

TAV-in-SAV in Japanese Patients
NCT06826027 ACTIVE_NOT_RECRUITING